Daily close · ICCCIEX trades only
Oct 29, 2024 to Nov 09, 2026 · 250 sessions10.22 USD
Built from trades executed at IEX only, one exchange with a small share of US volume. This is not the consolidated tape. The close is the last IEX trade of the session, not the official closing price. Earlier sessions are divided by the later split ratios the API confirmed against IEX prices; dividends are not adjusted. Switch to As traded for the prices as they printed. End of day, not real time: a session is published the day after it trades.
Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use. iex.io/legal/hist-data-terms
IMMUCELL CORP /DE/ (ICCC) financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2025 | FY2024 | Change | Source |
|---|---|---|---|---|
| Revenue | $27.6 million | $26.5 million | +4.3% | 10-K 2026-03-30 · proof |
| Gross profit | $11.4 million | $7.9 million | +44.1% | 10-K 2026-03-30 · proof |
| Operating income | $1.6 million | -$1.6 million | 10-K 2026-03-30 · proof | |
| Net income | -$1 million | -$2.2 million | 10-K 2026-03-30 · proof | |
| Cash from operating activities | $2.5 million | $357,903 | +591.6% | 10-K 2026-03-30 · proof |
| Free cash flow | $1.2 million | -$107,822 | 10-K 2026-03-30 · proof |
- What was IMMUCELL CORP /DE/ (ICCC)'s revenue in fiscal 2025?
- IMMUCELL CORP /DE/ (ICCC) reported revenue of $27.6 million for fiscal 2025 (the year ended Dec 31, 2025), against $26.5 million the year before (+4.3%). Source: the 10-K filed with the SEC on Mar 30, 2026. SEC
- What was IMMUCELL CORP /DE/ (ICCC)'s gross profit in fiscal 2025?
- IMMUCELL CORP /DE/ (ICCC) reported gross profit of $11.4 million for fiscal 2025 (the year ended Dec 31, 2025), against $7.9 million the year before (+44.1%). Source: the 10-K filed with the SEC on Mar 30, 2026. SEC
- What was IMMUCELL CORP /DE/ (ICCC)'s operating income in fiscal 2025?
- IMMUCELL CORP /DE/ (ICCC) reported operating income of $1.6 million for fiscal 2025 (the year ended Dec 31, 2025), against -$1.6 million the year before. Source: the 10-K filed with the SEC on Mar 30, 2026. SEC
- What was IMMUCELL CORP /DE/ (ICCC)'s net income in fiscal 2025?
- IMMUCELL CORP /DE/ (ICCC) reported net income of -$1 million for fiscal 2025 (the year ended Dec 31, 2025), against -$2.2 million the year before. Source: the 10-K filed with the SEC on Mar 30, 2026. SEC
- What was IMMUCELL CORP /DE/ (ICCC)'s cash from operating activities in fiscal 2025?
- IMMUCELL CORP /DE/ (ICCC) reported cash from operating activities of $2.5 million for fiscal 2025 (the year ended Dec 31, 2025), against $357,903 the year before (+591.6%). Source: the 10-K filed with the SEC on Mar 30, 2026. SEC
- What was IMMUCELL CORP /DE/ (ICCC)'s free cash flow in fiscal 2025?
- IMMUCELL CORP /DE/ (ICCC) reported free cash flow of $1.2 million for fiscal 2025 (the year ended Dec 31, 2025), against -$107,822 the year before. Source: the 10-K filed with the SEC on Mar 30, 2026. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=ticker:ICCC&period_type=annual&limit=5"Information only, not investment advice.